B Vitamins and Fatty Acids: What Do They Share with Small Vessel Disease-Related Dementia?
Open Access
- 18 November 2019
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (22) , 5797
Abstract
Many studies have been written on vitamin supplementation, fatty acid, and dementia, but results are still under debate, and no definite conclusion has yet been drawn. Nevertheless, a significant amount of lab evidence confirms that vitamins of the B group are tightly related to gene control for endothelium protection, act as antioxidants, play a co-enzymatic role in the most critical biochemical reactions inside the brain, and cooperate with many other elements, such as choline, for the synthesis of polyunsaturated phosphatidylcholine, through S-adenosyl-methionine (SAM) methyl donation. B-vitamins have anti-inflammatory properties and act in protective roles against neurodegenerative mechanisms, for example, through modulation of the glutamate currents and a reduction of the calcium currents. In addition, they also have extraordinary antioxidant properties. However, laboratory data are far from clinical practice. Many studies have tried to apply these results in everyday clinical activity, but results have been discouraging and far from a possible resolution of the associated mysteries, like those represented by Alzheimer’s disease (AD) or small vessel disease dementia. Above all, two significant problems emerge from the research: No consensus exists on general diagnostic criteria—MCI or AD? Which diagnostic criteria should be applied for small vessel disease-related dementia? In addition, no general schema exists for determining a possible correct time of implementation to have effective results. Here we present an up-to-date review of the literature on such topics, shedding some light on the possible interaction of vitamins and phosphatidylcholine, and their role in brain metabolism and catabolism. Further studies should take into account all of these questions, with well-designed and world-homogeneous trials.Keywords
This publication has 450 references indexed in Scilit:
- Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using MetabolomicsPLOS ONE, 2013
- Acetyl-CoA the Key Factor for Survival or Death of Cholinergic Neurons in Course of Neurodegenerative DiseasesNeurochemical Research, 2013
- Pathology and pathogenesis of vascular cognitive impairment—a critical updateFrontiers in Aging Neuroscience, 2013
- Continuous nicotinamide administration improves behavioral recovery and reduces lesion size following bilateral frontal controlled cortical impact injuryBehavioural Brain Research, 2011
- Microinfarcts, brain atrophy, and cognitive function: The Honolulu Asia Aging Study Autopsy StudyAnnals of Neurology, 2011
- Nicotinamide improves motor deficits and upregulates PGC-1α and BDNF gene expression in a mouse model of Huntington's diseaseNeurobiology of Disease, 2011
- Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defectsJournal of Inherited Metabolic Disease, 2010
- High-Dose B Vitamin Supplementation and Cognitive Decline in Alzheimer DiseaseJAMA, 2008
- Niacin restriction upregulates NADPH oxidase and reactive oxygen species (ROS) in human keratinocytesFree Radical Biology and Medicine, 2008
- Greater intake of vitamins B6 and B12 spares gray matter in healthy elderly: A voxel-based morphometry studyBrain Research, 2008